Short answer
ACACIA RESEARCH CORP (ACTG) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $54M (down 56.4% year over year) with net income of −$16M.
Q1 2026 key financials · XBRL
- Revenue
- $54M
- −56.4% YoY
- Net income
- −$16M
- −164.8% YoY
- Operating margin
- -15.4%
- Gross margin
- 22.2%
- EPS (diluted)
- −$0.16
- −164.0% YoY
Source: XBRL data from the ACACIA RESEARCH CORP (ACTG) Q1 2026 10-Q on SEC EDGAR. USD.
ACACIA RESEARCH CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Life Sciences proceeds $564.1M through March 31, 2026; retained securities valued at $25.7M
- Manufacturing headwinds from tariffs and challenging demand; no updated guidance disclosed
Risk Factors
- Risk factors section not provided; excerpt contains no new, updated, or carried-forward risk disclosures
- No regulatory, legal, compliance, operational, competitive, market, or financial risks stated in provided text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ACACIA RESEARCH CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.